Hanover - Delayed Quote EUR

Regeneron Pharmaceuticals Inc (RGO.HA)

Compare
683.60
-19.20
(-2.73%)
At close: January 10 at 5:25:19 PM GMT+1
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
33,080,200.00
29,214,500.00
25,434,800.00
17,163,300.00
Total Liabilities Net Minority Interest
7,107,100.00
6,550,500.00
6,666,000.00
6,138,000.00
Total Equity Gross Minority Interest
25,973,100.00
22,664,000.00
18,768,800.00
11,025,300.00
Total Capitalization
27,956,000.00
24,645,400.00
20,748,800.00
13,003,800.00
Common Stock Equity
25,973,100.00
22,664,000.00
18,768,800.00
11,025,300.00
Capital Lease Obligations
720,000.00
720,000.00
719,700.00
717,200.00
Net Tangible Assets
24,934,500.00
21,748,500.00
18,762,100.00
11,025,300.00
Working Capital
16,055,800.00
12,742,800.00
10,082,400.00
7,081,700.00
Invested Capital
27,956,000.00
24,645,400.00
20,748,800.00
13,003,800.00
Tangible Book Value
24,934,500.00
21,748,500.00
18,762,100.00
11,025,300.00
Total Debt
2,702,900.00
2,701,400.00
2,699,700.00
2,695,700.00
Share Issued
134,918.15
132,200.00
128,067.73
123,382.43
Ordinary Shares Number
109,418.15
109,600.00
108,674.77
106,950.91
Treasury Shares Number
25,500.00
22,600.00
19,392.96
16,431.52
12/31/2020 - 9/23/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers